Details of the Drug
General Information of Drug (ID: DM9OD7U)
| Drug Name |
6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE; 2,4-Diamino-5-phenyl-6-ethylpyrimidine; UNII-KMJ59LN22F; 2,4-Diamino-6-ethyl-5-phenylpyrimidine; TCMDC-124296; Pyrimidine, 2,4-diamino-6-ethyl-5-phenyl-; 27653-49-2; BRN 0190097; KMJ59LN22F; GNF-PF-26; CHEMBL22148; Diamino-5-phenyl-6-ethylpyrimidine, 2,4-; CP7; 2,4-Pyrimidinediamine, 6-ethyl-5-phenyl-; AC1L3PJ1; Oprea1_813184; SCHEMBL3498787; CTK8H9609; BDBM18788; DTXSID70182029; XREDUPOVEQDQQS-UHFFFAOYSA-N; MolPort-002-484-045; ZINC13282257; AKOS003622581; MCULE-8548953211; DB07577
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 214.27 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


